» Articles » PMID: 17383048

Expression of MMPs and TIMPs in Liver Fibrosis - a Systematic Review with Special Emphasis on Anti-fibrotic Strategies

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2007 Mar 27
PMID 17383048
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

In liver tissue matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitors of metalloproteinases, TIMPs) play a pivotal role in both, fibrogenesis and fibrolysis. The current knowledge of the pathophysiology of liver fibrogenesis with special emphasis on MMPs and TIMPs is presented. A systematic literature search was conducted. All experimental models of liver fibrosis that evaluated a defined anti-fibrotic intervention in vivo or in vitro considering MMPs and TIMPs were selected. The methodological quality of all these publications has been critically appraised using an objective scoring system and the content has been summarized in a table.

Citing Articles

[Fibrotic diseases in the gastrointestinal tract : Liver fibrosis and more].

Roeb E Inn Med (Heidelb). 2025; .

PMID: 40032677 DOI: 10.1007/s00108-025-01869-6.


New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?.

Tagliaferro M, Marino M, Basile V, Pocino K, Rapaccini G, Ciasca G J Pers Med. 2024; 14(8).

PMID: 39201990 PMC: 11355846. DOI: 10.3390/jpm14080798.


The proteomic landscape of in vitro cultured endothelial cells across vascular beds.

Groten S, Smit E, van den Biggelaar M, Hoogendijk A Commun Biol. 2024; 7(1):989.

PMID: 39143368 PMC: 11324761. DOI: 10.1038/s42003-024-06649-w.


miR-9-5p and miR-221-3p Promote Human Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Liver Injury by Enhancing Human Mesenchymal Stem Cell Engraftment and Inhibiting Hepatic Stellate Cell Activation.

He L, Xu J, Huang P, Bai Y, Chen H, Xu X Int J Mol Sci. 2024; 25(13).

PMID: 39000343 PMC: 11241704. DOI: 10.3390/ijms25137235.


Genome-wide RNA sequencing of ocular fibroblasts from glaucomatous and normal eyes: Implications for glaucoma management.

Roodnat A, Callaghan B, Doyle C, Vallabh N, Atkinson S, Willoughby C PLoS One. 2024; 19(7):e0307227.

PMID: 38990974 PMC: 11239048. DOI: 10.1371/journal.pone.0307227.